Antibody-Mediated Modulation of Melanoma-Associated Antigens: Access of Monoclonal Antibodies into Melanoma Cells and Melanoma Tissue

This publication has 17 references indexed in Scilit:

• Criteria for selecting monoclonal antibodies with respect to accumulation in melanoma tissue
  Cancer Immunology, Immunotherapy, 1987
• Transport of Macromolecules In Tumor Microcirculation
  Biotechnology Progress, 1985
• Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experience.
  Radiology, 1985
• Antigenic modulation - a major mechanism of antibody action
  Immunology Today, 1984
• Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
  Journal of Clinical Investigation, 1983
• A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo
  Biochemical Journal, 1983
• Melanoma‐associated antigen p97 continues to be expressed after prolonged exposure of cells to specific antibody
  International Journal of Cancer, 1983
• Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma‐associated antigen p97
  International Journal of Cancer, 1982
• Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells.
  Proceedings of the National Academy of Sciences, 1982
• Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
  Proceedings of the National Academy of Sciences, 1980